The Anti-Epileptic Drugs Lamotrigine and Valproic Acid Reduce the Cardiac Sodium Current.
Lixia JiaArjan C HouwelingHanno L TanPublished in: Biomedicines (2023)
Anti-epileptic drugs (AEDs) are associated with increased risk of sudden cardiac death. To establish whether gabapentin, lamotrigine, levetiracetam, pregabalin, and valproic acid reduce the Na v 1.5 current, we conducted whole-cell patch-clamp studies to study the effects of the five AEDs on currents of human cardiac Na v 1.5 channels stably expressed in HEK293 cells, and on action potential (AP) properties of freshly isolated rabbit ventricular cardiomyocytes. Lamotrigine and valproic acid exhibited inhibitory effects on the Na v 1.5 current in a concentration-dependent manner with an IC 50 of 142 ± 36 and 2022 ± 25 µM for lamotrigine and valproic acid, respectively. In addition, these drugs caused a hyperpolarizing shift of steady-state inactivation and a delay in recovery from inactivation. The changes on the Na v 1.5 properties were reflected by a reduction in AP upstroke velocity (43.0 ± 6.8% (lamotrigine) and 23.7 ± 10.6% (valproic acid) at 1 Hz) and AP amplitude; in contrast, AP duration was not changed. Gabapentin, levetiracetam, and pregabalin had no effect on the Na v 1.5 current. Lamotrigine and valproic acid reduce the Na v 1.5 current density and affect its gating properties, resulting in a decrease of the AP upstroke velocity. Gabapentin, levetiracetam, and pregabalin have no effects on the Na v 1.5 current.
Keyphrases
- neuropathic pain
- transcription factor
- left ventricular
- heart failure
- endothelial cells
- magnetic resonance
- spinal cord injury
- stem cells
- spinal cord
- risk assessment
- oxidative stress
- postoperative pain
- cell therapy
- cell cycle arrest
- mesenchymal stem cells
- atrial fibrillation
- functional connectivity
- induced pluripotent stem cells
- catheter ablation
- high glucose